Wang Z, Yu J, Zhu W, Hong X, Xu Z, Mao S
Mol Cancer. 2024; 23(1):276.
PMID: 39707444
PMC: 11660679.
DOI: 10.1186/s12943-024-02187-5.
Engel J, Zhang X, Wu M, Wang Y, Espejo Valle-Inclan J, Hu Q
Cell. 2024; 187(21):6055-6070.e22.
PMID: 39181133
PMC: 11490392.
DOI: 10.1016/j.cell.2024.08.001.
Rose J, Belk J, Wong I, Luebeck J, Horn H, Daniel B
Cancer Discov. 2024; 15(1):69-82.
PMID: 39109936
PMC: 11726015.
DOI: 10.1158/2159-8290.CD-23-1117.
Tasnim M, Wahlquist P, Hill J
Dev Genes Evol. 2024; 234(2):99-116.
PMID: 39079985
PMC: 11612004.
DOI: 10.1007/s00427-024-00720-6.
Zhou L, Tang W, Ye B, Zou L
Front Genet. 2024; 15:1385150.
PMID: 38746056
PMC: 11092383.
DOI: 10.3389/fgene.2024.1385150.
Categorizing Extrachromosomal Circular DNA as Biomarkers in Serum of Cancer.
Deng E, Fan X
Biomolecules. 2024; 14(4).
PMID: 38672504
PMC: 11048305.
DOI: 10.3390/biom14040488.
Imaging extrachromosomal DNA (ecDNA) in cancer.
Purshouse K, Pollard S, Bickmore W
Histochem Cell Biol. 2024; 162(1-2):53-64.
PMID: 38625562
PMC: 7616135.
DOI: 10.1007/s00418-024-02280-2.
Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance.
Meng X, Ma J, Liu Y, Li S, Wang X, Zhu J
Br J Cancer. 2024; 130(11):1819-1827.
PMID: 38594370
PMC: 11130306.
DOI: 10.1038/s41416-024-02664-0.
Insight on ecDNA-mediated tumorigenesis and drug resistance.
Huang Q, Zhang S, Wang G, Han J
Heliyon. 2024; 10(6):e27733.
PMID: 38545177
PMC: 10966608.
DOI: 10.1016/j.heliyon.2024.e27733.
Dynamics of extrachromosomal circular DNA in rice.
Zhuang J, Zhang Y, Zhou C, Fan D, Huang T, Feng Q
Nat Commun. 2024; 15(1):2413.
PMID: 38499575
PMC: 10948907.
DOI: 10.1038/s41467-024-46691-0.
Disparate pathways for extrachromosomal DNA biogenesis and genomic DNA repair.
Rose J, Wong I, Daniel B, Jones M, Yost K, Hung K
bioRxiv. 2023; .
PMID: 37961138
PMC: 10634728.
DOI: 10.1101/2023.10.22.563489.
Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications.
Dong Y, He Q, Chen X, Yang F, He L, Zheng Y
Front Oncol. 2023; 13:1194405.
PMID: 37448518
PMC: 10338009.
DOI: 10.3389/fonc.2023.1194405.
EccBase: A high-quality database for exploration and characterization of extrachromosomal circular DNAs in cancer.
Sun H, Lu X, Zou L
Comput Struct Biotechnol J. 2023; 21:2591-2601.
PMID: 37114214
PMC: 10126927.
DOI: 10.1016/j.csbj.2023.04.012.
Use of ubiquitous chromatin opening elements (UCOE) as tools to maintain transgene expression in biotechnology.
Sizer R, White R
Comput Struct Biotechnol J. 2022; 21:275-283.
PMID: 36582439
PMC: 9764128.
DOI: 10.1016/j.csbj.2022.11.059.
Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.
Pecorino L, Verhaak R, Henssen A, Mischel P
Biochem Soc Trans. 2022; 50(6):1911-1920.
PMID: 36355400
PMC: 9788557.
DOI: 10.1042/BST20221045.
Extrachromosomal circular DNA: biogenesis, structure, functions and diseases.
Yang L, Jia R, Ge T, Ge S, Zhuang A, Chai P
Signal Transduct Target Ther. 2022; 7(1):342.
PMID: 36184613
PMC: 9527254.
DOI: 10.1038/s41392-022-01176-8.
Extrachromosomal DNA amplifications in cancer.
Yi E, Chamorro Gonzalez R, Henssen A, Verhaak R
Nat Rev Genet. 2022; 23(12):760-771.
PMID: 35953594
PMC: 9671848.
DOI: 10.1038/s41576-022-00521-5.
Extrachromosomal circular DNA (eccDNA): an emerging star in cancer.
Li R, Wang Y, Li J, Zhou X
Biomark Res. 2022; 10(1):53.
PMID: 35883211
PMC: 9327165.
DOI: 10.1186/s40364-022-00399-9.
Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
Li Z, Wang B, Liang H, Han L
Int J Biol Sci. 2022; 18(10):4006-4025.
PMID: 35844796
PMC: 9274496.
DOI: 10.7150/ijbs.73479.
Extrachromosomal DNA in Cancer.
Bafna V, Mischel P
Annu Rev Genomics Hum Genet. 2022; 23:29-52.
PMID: 35609926
PMC: 10508221.
DOI: 10.1146/annurev-genom-120821-100535.
